Literature DB >> 19148354

[The application of MELD score in patients submitted to liver transplantation: a retrospective analysis of survival and the predictive factors in the short and long term].

Ilka de Fátima Santana Ferreira Boin1, Marília Iracema Leonardi, Elisabete Yoko Udo, Tiago Sevá-Pereira, Raquel Silveira Bello Stucchi, Luiz Sergio Leonardi.   

Abstract

BACKGROUND: The model for end-stage liver disease (MELD) was developed to predict short-term mortality in patients with cirrhosis. There are few reports studying the correlation between MELD and long-term posttransplantation survival. AIM: To assess the value of pretransplant MELD in the prediction of posttransplant survival.
METHODS: The adult patients (age >18 years) who underwent liver transplantation were examined in a retrospective longitudinal cohort of patients, through the prospective data base. We excluded acute liver failure, retransplantation and reduced or split-livers. The liver donors were evaluated according to: age, sex, weight, creatinine, bilirubin, sodium, aspartate aminotransferase, personal antecedents, brain death cause, steatosis, expanded criteria donor number and index donor risk. The recipients' data were: sex, age, weight, chronic hepatic disease, Child-Turcotte-Pugh points, pretransplant and initial MELD score, pretransplant creatinine clearance, sodium, cold and warm ischemia times, hospital length of stay, blood requirements, and alanine aminotransferase (ALT >1,000 UI/L = liver dysfunction). The Kaplan-Meier method with the log-rank test was used for the univariable analyses of posttransplant patient survival. For the multivariable analyses the Cox proportional hazard regression method with the stepwise procedure was used with stratifying sodium and MELD as variables. ROC curve was used to define area under the curve for MELD and Child-Turcotte-Pugh.
RESULTS: A total of 232 patients with 10 years follow up were available. The MELD cutoff was 20 and Child-Turcotte-Pugh cutoff was 11.5. For MELD score > or =20, the risk factors for death were: red cell requirements, liver dysfunction and donor's sodium. For the patients with hyponatremia the risk factors were: negative delta-MELD score, red cell requirements, liver dysfunction and donor's sodium. The regression univariated analyses came up with the following risk factors for death: score MELD > or = 25, blood requirements, recipient creatinine clearance pretransplant and age donor > or =50. After stepwise analyses, only red cell requirement was predictive. Patients with MELD score < 25 had a 68.86%, 50,44% and 41,50% chance for 1, 5 and 10-year survival and > or =25 were 39.13%, 29.81% and 22.36% respectively. Patients without hyponatremia were 65.16%, 50.28% and 41,98% and with hyponatremia 44.44%, 34.28% and 28.57% respectively. Patients with IDR > or =1.7 showed 53.7%, 27.71% and 13.85% and index donor risk <1.7 was 63.62%, 51.4% and 44.08%, respectively. Age donor > 50 years showed 38.4%, 26.21% and 13.1% and age donor < or =50 years showed 65.58%, 26.21% and 13.1%. Association with delta-MELD score did not show any significant difference. Expanded criteria donors were associated with primary non-function and severe liver dysfunction. Predictive factors for death were blood requirements, hyponatremia, liver dysfunction and donor's sodium.
CONCLUSION: In conclusion MELD over 25, recipient's hyponatremia, blood requirements, donor's sodium were associated with poor survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19148354     DOI: 10.1590/s0004-28032008000400004

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  7 in total

Review 1.  Electrolyte and Acid-Base Disturbances in End-Stage Liver Disease: A Physiopathological Approach.

Authors:  José Víctor Jiménez; Diego Luis Carrillo-Pérez; Rodrigo Rosado-Canto; Ignacio García-Juárez; Aldo Torre; David Kershenobich; Eduardo Carrillo-Maravilla
Journal:  Dig Dis Sci       Date:  2017-05-13       Impact factor: 3.199

Review 2.  THE IMPACT OF THE MELD SCORE ON LIVER TRANSPLANT ALLOCATION AND RESULTS: AN INTEGRATIVE REVIEW.

Authors:  Ana Claudia Oliveira de Moraes; Priscilla Caroliny de Oliveira; Olival Cirilo Lucena da Fonseca-Neto
Journal:  Arq Bras Cir Dig       Date:  2017 Jan-Mar

3.  Incidence and Predictors of Advanced Liver Fibrosis by a Validated Serum Biomarker in Liver Transplant Recipients.

Authors:  Mamatha Bhat; Kathleen C Rollet-Kurhajec; Aparna Bhat; Amanda Farag; Marc Deschenes; Philip Wong; Peter Ghali; Giada Sebastiani
Journal:  Can J Gastroenterol Hepatol       Date:  2017-03-19

Review 4.  Cardiovascular and Metabolic Consequences of Liver Transplantation: A Review.

Authors:  Oana Plotogea; Madalina Ilie; Vasile Sandru; Alexandru Chiotoroiu; Ovidiu Bratu; Camelia Diaconu
Journal:  Medicina (Kaunas)       Date:  2019-08-15       Impact factor: 2.430

5.  BAR, SOFT AND DRI POST-HEPATIC TRANSPLANTATION: WHAT IS THE BEST FOR SURVIVAL ANALYSIS?

Authors:  Fernando Torterolli; Rafael Katsunori Watanabe; Fernando Issamu Tabushi; Igor Luna Peixoto; Paulo Afonso Nunes Nassif; Nertan Luiz Tefilli; Sergio Luiz Rocha; Osvaldo Malafaia
Journal:  Arq Bras Cir Dig       Date:  2021-06-11

Review 6.  Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Ying Peng; Xingshun Qi; Xiaozhong Guo
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

7.  EFFECTS OF COLD ISCHEMIA TIME ON HEPATIC ALLOGRAFT FUNCTION.

Authors:  Alexandre Coutinho Teixeira de Freitas; Desirée de Marillac Nascimento de Matos; Jorge Amilton Tosato Milsted; Julio Cezar Uili Coelho
Journal:  Arq Bras Cir Dig       Date:  2017 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.